Sleet Strikes Patents in Suit Over Respiratory Treatment
A Delaware federal judge on Tuesday extinguished Mallinckrodt Pharmaceuticals' patent infringement suit against industrial gases company Praxair Inc., striking five of the Irish drugmaker's patents for its INOMAX respiratory treatment system as invalid and ruling that Praxair had not infringed on five more.
This premium content is reserved for Delaware Law Weekly subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now